Shaoxi Diao

机构：Anhui Medical University

发表论文 9 篇 · 总被引 107 次 · h-index 6

代表论文

• Decoding m6A mRNA methylation by reader proteins in liver diseases (2023 · Genes & Diseases · 被引 23)
• Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway (2024 · Biochemical Pharmacology · 被引 21)
• Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosis (2025 · EBioMedicine · 被引 15)
• Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice (2022 · Biochemical Pharmacology · 被引 14)
• DNMT3a-mediated methylation of TCF21/hnRNPA1 aggravates hepatic fibrosis by regulating the NF-κB signaling pathway (2023 · Pharmacological Research · 被引 13)
• Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2 (2023 · Acta Pharmacologica Sinica · 被引 9)